Literature DB >> 1410131

Interaction of sigma and PCP-like drugs on operant behaviors in the rat.

T J Hudzik1, B L Slifer.   

Abstract

Many PCP-like drugs interact with at least two types of binding sites in the CNS, one of which is linked to excitatory amino acid transmission and the other with an unknown function. The present experiments were designed to further clarify the mechanism of action of drugs in this class. Assessment was made of the effects of PCP, MK-801, (+)-pentazocine, (+)- and (-)-N-allyl-normetazocine (NANM), (+)-amphetamine and BMY-14802 in rats responding under a multiple timeout 600 s (TO), differential reinforcement of low rates 10 s (DRL), fixed ratio (FR) 10 schedule of reinforcement. The effects of the PCP-receptor selective drug MK-801 were compared to those of the mixed sigma/PCP drug (+)-NANM after each were combined with doses of (+)-pentazocine, PCP, BMY-14802, and (+)-amphetamine. MK-801 was also tested in combination with (+)-NANM, as was PCP with BMY-14802. When administered alone, MK-801, PCP, (+)-NANM, (+)-pentazocine, and (+)-amphetamine increased rates of responding under the DRL component of the multiple schedule. The drugs tested generally produced decreases in rates of responding under the FR component. (+)-Pentazocine and BMY-14802 did not modify the effects of (+)-NANM or of MK-801. PCP enhanced the effects of MK-801 and (+)-NANM, and (+)-amphetamine enhanced the effects of MK-801 but not of (+)-NANM. BMY-14802 attenuated the effects of PCP. Taken together, these data suggest similarities as well as some differences in the pharmacologic activities of MK-801 and (+)-NANM and PCP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410131     DOI: 10.1007/bf02245295

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

Review 1.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

2.  Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain.

Authors:  R C Smith; H Y Meltzer; R C Arora; J M Davis
Journal:  Biochem Pharmacol       Date:  1977-08-01       Impact factor: 5.858

3.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

4.  Structure-activity relationships of arylcyclohexylamines as discriminative stimuli in pigeons.

Authors:  D E McMillan; E B Evans; W D Wessinger; S M Owens
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

5.  The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.

Authors:  R B Rothman; A A Reid; J A Monn; A E Jacobson; K C Rice
Journal:  Mol Pharmacol       Date:  1989-12       Impact factor: 4.436

6.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: structure-activity studies.

Authors:  W Koek; J H Woods; M V Mattson; A E Jacobson; P J Mudar
Journal:  Neuropharmacology       Date:  1987-09       Impact factor: 5.250

8.  d-Amphetamine and phencyclidine alone and in combination: effects on fixed-ratio and interresponse-time-greater-than-t responding of rats.

Authors:  A Poling; J Cleary; K Jackson; S Wallace
Journal:  Pharmacol Biochem Behav       Date:  1981-09       Impact factor: 3.533

9.  Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes.

Authors:  J P Vincent; B Kartalovski; P Geneste; J M Kamenka; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

10.  MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

Authors:  W Koek; J H Woods; G D Winger
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

View more
  4 in total

1.  AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks.

Authors:  D N Stephens; B J Cole
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

Review 2.  Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia.

Authors:  Nurith Amitai; Athina Markou
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

3.  Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine.

Authors:  Jenny L Wiley; Amelia D Compton
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

4.  Drug effects on response duration differentiation. I: Differential effects of drugs of abuse.

Authors:  T J Hudzik; D E McMillan
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.